WWW.PHARMAORG.COM WWW.PHARMAORG.COM: Any drug you wish to know about


Choose any drug you wish to know about and how to use it
A
Aciphex
Acyclovir
Albenza
Aldactone
Aldara
Alesse
Allegra
Allegra D
Amoxicillin
Antivert
Aphthasol
Atarax
B
Bentyl
Buspar
Butalbital-Apap
C
Carisoprodol
Celexa
Cialis
Clarinex
Claritin-D
Cleocin-T Gel
Colchicine
Condylox
Cyclobenzaprine
D
Denavir
Detrol LA
Diflucan
Diprolene AF
Dovonex
E
Effexor XR
Elavil
Elidel
Elimite
Esgic Plus
Estradiol
Eurax
Evista
F
Famvir
Fioricet
Flexeril
Flextra DS
Flonase
Fluoxetine
Fosamax
G
Gris-Peg
I
Imitrex
K
Kenalog
Kenalog Aerosol
L
Lamisil Oral
Levbid
Levitra
Lexapro
Lipitor
M
Microzide
Mircette
Motrin
N
Naprosyn
Nasacort AQ
Nasonex
Nexium
Nizoral
Norvasc
O
Ortho Evra
Ortho Tricyclen
Ortho Tricyclen LO
P
Patanol
Paxil
Paxil CR
Penlac
Prevacid
Prilosec
Propecia
Protopic
Prozac
R
Ranitidine HCL
Remeron
Renova
Retin-A
S
Seasonale
Skelaxin
Soma
Sumycin
Synalar
Synalar Cream
T
Tamiflu
Temovate
Tetracycline
Tramadol
Transderm Scop
Triphasil
U
Ultracet
Ultram
V
Valtrex
Vaniqa
Vermox
Viagra
W
Wellbutrin
Wellbutrin SR
X
Xenical
Y
Yasmin
Z
Zanaflex
Zithromax
Zoloft
Zovirax
Zyban
Zyloprim
Zyrtec

Searching for something else? No problem!

Search for anything:

Implanted Nerve Stimulator Eases Epilepsy in Kids.
         Stimulation of a cranial nerve through an implant can effectively treat some children with epilepsy, according to the results of a new two-year study. In a study of more than 75 young patients, doctors found that 59 percent of those implanted with a vagus nerve stimulator did not suffer from localization-related epilepsy, or seizures occurring in one part of the brain. Hospital visits for epilepsy-related conditions also decreased by 41 percent, the researchers reported Wednesday at the International League Against Epilepsy Congress in Paris. The nerve stimulator is implanted in the left side of a patient's neck and works by sending signals to the brain to decrease the electrical activity that leads to seizures. It was approved by the U.S. Food and Drug Administration in 1997 for the treatment of epilepsy unresponsive to medication.
Main Page  Site Map